Bactroban and Atypical femur fracture - a phase IV clinical study of FDA data

Summary:

Atypical femur fracture is found among people who take Bactroban, especially for people who are female, 60+ old.

The phase IV clinical study analyzes which people take Bactroban and have Atypical femur fracture. It is created by eHealthMe based on reports of 4,457 people who have side effects when taking Bactroban from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

4,457 people reported to have side effects when taking Bactroban.
Among them, 6 people (0.13%) have Atypical femur fracture.

What is Bactroban?

Bactroban has active ingredients of mupirocin. It is often used in infection. eHealthMe is studying from 4,504 Bactroban users for its effectiveness, alternative drugs and more.

What is Atypical femur fracture?

Atypical femur fracture is found to be associated with 548 drugs and 204 conditions by eHealthMe.

Number of Bactroban and Atypical femur fracture reports submitted per year:

$Could Bactroban cause Atypical femur fracture?$

Gender of people who have Atypical femur fracture when taking Bactroban *:

female: 100 %
male: 0.0 %

Age of people who have Atypical femur fracture when taking Bactroban *:

Common drugs people take besides Bactroban *:

Common side effects people have besides Atypical femur fracture *:

Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 6 people, 100.00%
Rib Fracture: 6 people, 100.00%
Renal Impairment (severely reduced kidney function): 6 people, 100.00%
Dystrophic Calcification (calcification occurring in degenerated or necrotic tissue): 6 people, 100.00%
Osteoporotic Fracture (fracture due to weak bone): 3 people, 50.00%

Common conditions people have *:

Polymyalgia Rheumatica (pain in many muscles): 3 people, 50.00%
Osteoporosis Post-Menopausal (weak bone with possibility to break after stopped menstrual cycles): 3 people, 50.00%
Neuralgia (pain in one or more nerves): 3 people, 50.00%
Nausea (feeling of having an urge to vomit): 3 people, 50.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Bactroban and have Atypical femur fracture?

Check whether Atypical femur fracture is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Atypical femur fracture and when was it recovered:

Atypical femur fracture in Bactroban

Expand to all the drugs that have ingredients of mupirocin:

Atypical femur fracture and drugs with ingredients of mupirocin

Alternative drugs to, pros and cons of Bactroban:

Bactroban (4,504 reports)

Common Bactroban side effects:

Fatigue (feeling of tiredness): 435 reports
Drug ineffective: 413 reports
Pain: 396 reports
Rashes (redness): 340 reports
Breathing difficulty: 331 reports
Diarrhea: 307 reports
Stress and anxiety: 292 reports

Browse all side effects of Bactroban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Atypical femur fracture treatments and more:

Atypical femur fracture (2,757 reports)

COVID vaccines that are related to Atypical femur fracture:

Common drugs associated with Atypical femur fracture:

How the study uses the data?

The study uses data from the FDA. It is based on mupirocin (the active ingredients of Bactroban) and Bactroban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.